Indian startup takes AI-powered breast cancer screening to Asia

Indian health care startup Niramai Health Analytix is in talks with Asian hospitals for its noninvasive, artificial intelligence-enabled technology to screen for early signs of breast cancer. The startup has raised about $7 million from Japan's Dream Incubator and local investors Pi Ventures, Axilor and Flipkart co-founder Binny Bansal, among others. It is now preparing pretrials in South and Southeast Asian countries with a high incidence of breast cancer. According to the World Health Organization, Asia accounted for 43.6% of the 2.09 million breast cancer cases globally in 2018. The organization also noted that breast cancer is the most common cancer in women, both in developed and less developed nations.